Mexico: COFEPRIS Approval and Cross-Border Purchasing Questions
Mexico's COFEPRIS regulates GLP-1 drugs domestically, and the country has become a common topic in discussions of cross-border purchasing by U.S. patients.
By the GLP Semaglutide editorial team · Last updated December 12, 2025
Mexico's Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) is the national regulator responsible for drug approval and pharmacy oversight, including GLP-1 receptor agonists sold within Mexico.
Why cross-border purchasing comes up
Price differences have led some U.S. residents to consider purchasing medication in Mexico. Personal importation of prescription drugs into the U.S. is subject to federal rules that generally restrict it outside narrow circumstances, regardless of where the drug was legally purchased.
Verification matters more, not less, across a border
A pharmacy operating legally under COFEPRIS oversight is a different thing from an unlicensed seller — verifying licensure with COFEPRIS directly is a reasonable step for anyone evaluating a specific pharmacy, independent of the separate U.S. importation legal question.